Bilateral Supra-Zygomatic Sphenopalatine Ganglion Block Versus Dexmedetomidine for Relief of Postoperative Pain and Surgical Field Improvement in Trans-nasal Endoscopic Pituitary Surgery

NCT06639659 NA ACTIVE_NOT_RECRUITING

Improving pain and surgical field by using sphenopalatine ganglion block and dexmedetomidine in trans-nasal endoscopic pituitary surgery.

Details

Lead sponsor	Zagazig University
Phase	NA
Status	ACTIVE_NOT_RECRUITING
Enrolment	69
Start date	2024-10-01
Completion	2026-10

Conditions

• Sphenopalatine Ganglion Nerve Block
• Transnasal Endoscopic Pitutary Surgery

Interventions

• Sphenopalatine Ganglion Block
• Dexmedetomidine
• General Anesthesia (control group)

Primary outcomes

• Postoperative pain using VAS scale. — 24hours
  Pain will be assessed based on VAS scale from (1-10), as 1 is the least pain and 10 is the maximal pain possible at 2, 4, 6, 12 and 24h after surgery.
• Surgical field using Average Category Scale (ACS). — 5hours
  Done by asking the surgeon about amount of bleeding on a scale of (0-5) as 0= no bleeding and 5= sever bleeding, every 15 min interval till the end of surgery.

Countries

Egypt